In summary, targeting ApoE4 in AD is a multifaceted approach, involving the reduction of ApoE levels, stabilization of its structure, modulation of lipid transport, and even gene editing techniques through a variety of mechanisms of action and routes of delivery. Here, APOE is linked to Alzheimer disease.